Achieve Life Sciences ACHV
NASDAQ ACHV
$6.78 +0.06 (+0.89%)
At close: Nov 9, 2026 · 4:00 PM EST

Achieve Life Sciences (ACHV) Non-Current Deferred Revenue (2010 - 2011)

Updated

Achieve Life Sciences (ACHV) reported Non-Current Deffered Revenue of $9.04 million for Q3 2011, down 8.4% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Non-Current Deferred Revenue (2010 - 2011) Analysis & Trends

At the end of FY2010, Achieve Life Sciences posted Non-Current Deffered Revenue of $11.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Achieve Life Sciences 746.03 Mn 544.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 9.04 Mn
Jun 30, 2011 9.87 Mn
Dec 31, 2010 11.62 Mn
API Access

Achieve Life Sciences Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ACHV&period=max&api_key=YOUR_API_KEY